448 related articles for article (PubMed ID: 21961046)
1. Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells.
Lathia JD; Gallagher J; Myers JT; Li M; Vasanji A; McLendon RE; Hjelmeland AB; Huang AY; Rich JN
PLoS One; 2011; 6(9):e24807. PubMed ID: 21961046
[TBL] [Abstract][Full Text] [Related]
2. Brain tumor stem cells from an adenoid glioblastoma multiforme.
Oka N; Soeda A; Noda S; Iwama T
Neurol Med Chir (Tokyo); 2009 Apr; 49(4):146-50; discussion 150-1. PubMed ID: 19398857
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma cancer stem cells--from concept to clinical application.
Stopschinski BE; Beier CP; Beier D
Cancer Lett; 2013 Sep; 338(1):32-40. PubMed ID: 22668828
[TBL] [Abstract][Full Text] [Related]
4. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary interpretation on the relationship between the phenotype of CD133+ cells and niche in transplanted human glioma in mice].
Song WC; Fei XF; Dong J
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):564-9. PubMed ID: 21122405
[TBL] [Abstract][Full Text] [Related]
6. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.
Fan X; Khaki L; Zhu TS; Soules ME; Talsma CE; Gul N; Koh C; Zhang J; Li YM; Maciaczyk J; Nikkhah G; Dimeco F; Piccirillo S; Vescovi AL; Eberhart CG
Stem Cells; 2010 Jan; 28(1):5-16. PubMed ID: 19904829
[TBL] [Abstract][Full Text] [Related]
7. Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression.
Hale JS; Otvos B; Sinyuk M; Alvarado AG; Hitomi M; Stoltz K; Wu Q; Flavahan W; Levison B; Johansen ML; Schmitt D; Neltner JM; Huang P; Ren B; Sloan AE; Silverstein RL; Gladson CL; DiDonato JA; Brown JM; McIntyre T; Hazen SL; Horbinski C; Rich JN; Lathia JD
Stem Cells; 2014 Jul; 32(7):1746-58. PubMed ID: 24737733
[TBL] [Abstract][Full Text] [Related]
8. Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance-associated protein genes.
Jin F; Zhao L; Zhao HY; Guo SG; Feng J; Jiang XB; Zhang SL; Wei YJ; Fu R; Zhao JS
Neuroscience; 2008 Jun; 154(2):541-50. PubMed ID: 18462887
[TBL] [Abstract][Full Text] [Related]
9. Altered lipid metabolism marks glioblastoma stem and non-stem cells in separate tumor niches.
Shakya S; Gromovsky AD; Hale JS; Knudsen AM; Prager B; Wallace LC; Penalva LOF; Brown HA; Kristensen BW; Rich JN; Lathia JD; Brown JM; Hubert CG
Acta Neuropathol Commun; 2021 May; 9(1):101. PubMed ID: 34059134
[TBL] [Abstract][Full Text] [Related]
10. The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells.
Jamal M; Rath BH; Tsang PS; Camphausen K; Tofilon PJ
Neoplasia; 2012 Feb; 14(2):150-8. PubMed ID: 22431923
[TBL] [Abstract][Full Text] [Related]
11. CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays.
He J; Liu Y; Zhu T; Zhu J; Dimeco F; Vescovi AL; Heth JA; Muraszko KM; Fan X; Lubman DM
Mol Cell Proteomics; 2012 Jun; 11(6):M111.010744. PubMed ID: 22203689
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem cell labeling using poly(L-lysine)-modified iron oxide nanoparticles.
Wang X; Wei F; Liu A; Wang L; Wang JC; Ren L; Liu W; Tu Q; Li L; Wang J
Biomaterials; 2012 May; 33(14):3719-32. PubMed ID: 22342710
[TBL] [Abstract][Full Text] [Related]
13. Neural stem cells and glioblastoma.
Rispoli R; Conti C; Celli P; Caroli E; Carletti S
Neuroradiol J; 2014 Apr; 27(2):169-74. PubMed ID: 24750704
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cells promote stem-like phenotype of glioma cells through activating the Hedgehog pathway.
Yan GN; Yang L; Lv YF; Shi Y; Shen LL; Yao XH; Guo QN; Zhang P; Cui YH; Zhang X; Bian XW; Guo DY
J Pathol; 2014 Sep; 234(1):11-22. PubMed ID: 24604164
[TBL] [Abstract][Full Text] [Related]
15. Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo.
deCarvalho AC; Nelson K; Lemke N; Lehman NL; Arbab AS; Kalkanis S; Mikkelsen T
Stem Cells; 2010 Feb; 28(2):181-90. PubMed ID: 19937755
[TBL] [Abstract][Full Text] [Related]
16. Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57.
Zhu X; Prasad S; Gaedicke S; Hettich M; Firat E; Niedermann G
Oncotarget; 2015 Jan; 6(1):171-84. PubMed ID: 25426558
[TBL] [Abstract][Full Text] [Related]
17. Identifying conserved molecular targets required for cell migration of glioblastoma cancer stem cells.
Volovetz J; Berezovsky AD; Alban T; Chen Y; Lauko A; Aranjuez GF; Burtscher A; Shibuya K; Silver DJ; Peterson J; Manor D; McDonald JA; Lathia JD
Cell Death Dis; 2020 Feb; 11(2):152. PubMed ID: 32102991
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma and stem cells.
Altaner C
Neoplasma; 2008; 55(5):369-74. PubMed ID: 18665745
[TBL] [Abstract][Full Text] [Related]
19. Integrin alpha 6 regulates glioblastoma stem cells.
Lathia JD; Gallagher J; Heddleston JM; Wang J; Eyler CE; Macswords J; Wu Q; Vasanji A; McLendon RE; Hjelmeland AB; Rich JN
Cell Stem Cell; 2010 May; 6(5):421-32. PubMed ID: 20452317
[TBL] [Abstract][Full Text] [Related]
20. Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme.
Wang J; Wang X; Jiang S; Lin P; Zhang J; Wu Y; Xiong Z; Ren JJ; Yang H
Cell Mol Neurobiol; 2008 Nov; 28(7):991-1003. PubMed ID: 18350379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]